Growing community of inventors

Seehausen, Germany

Dominik Ruettinger

Average Co-Inventor Count = 5.14

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 23

Dominik RuettingerCarola Ries (3 patents)Dominik RuettingerSabine Hoves (2 patents)Dominik RuettingerKatharina Wartha (1 patent)Dominik RuettingerMartin Weisser (1 patent)Dominik RuettingerMichael Cannarile (1 patent)Dominik RuettingerHadassah Sumum Sade (1 patent)Dominik RuettingerFrancesca Michielin (1 patent)Dominik RuettingerChia-Huey Ooi (1 patent)Dominik RuettingerSolange Romagnoli (1 patent)Dominik RuettingerAnna-Maria Jegg (1 patent)Dominik RuettingerTim Becker (0 patent)Dominik RuettingerAnna Bauer-mehren (0 patent)Dominik RuettingerKatharina Wartha (0 patent)Dominik RuettingerDominik Ruettinger (3 patents)Carola RiesCarola Ries (21 patents)Sabine HovesSabine Hoves (11 patents)Katharina WarthaKatharina Wartha (4 patents)Martin WeisserMartin Weisser (3 patents)Michael CannarileMichael Cannarile (2 patents)Hadassah Sumum SadeHadassah Sumum Sade (2 patents)Francesca MichielinFrancesca Michielin (1 patent)Chia-Huey OoiChia-Huey Ooi (1 patent)Solange RomagnoliSolange Romagnoli (1 patent)Anna-Maria JeggAnna-Maria Jegg (1 patent)Tim BeckerTim Becker (0 patent)Anna Bauer-mehrenAnna Bauer-mehren (0 patent)Katharina WarthaKatharina Wartha (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Hoffmann-la Roche Inc. (3 from 4,948 patents)

2. F. Hoffmann-la Roche Ag (168 patents)


3 patents:

1. 11542335 - Method of treating cancer in a patient by administering an antibody which binds colony stimulating factor-1 receptor (CSF-1R)

2. 11498968 - Treatment of tumors with an anti-CSF-1R antibody in combination with an anti-PD-L1 antibody after failure of anti-PD-L1/PD1 treatment

3. 9192667 - Method of treating cancer by administering CSF-1R antibodies and a TLR9 agonist

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…